GlassScriptPhysician profile
Charisse L Mccall
NPI 1073802450
$15,067.88
in general payments reported to CMS, 2019-2025
39 companies · $3,010 in 2025
The $3,010 reported for 2025 was more than what 84% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,347 · 2020: $1,642 · 2021: $1,822 · 2022: $2,063 · 2023: $1,622 · 2024: $2,562 · 2025: $3,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,971 · Education: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,971.36 |
| Education | $223.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $2,425.98 | 2023-2025 | Zoryve |
| Janssen Biotech, INC. | $1,397.54 | 2021-2025 | Tremfya, Simponi, Stelara |
| Novartis Pharmaceuticals Corporation | $1,380.95 | 2019-2025 | |
| Abbvie INC. | $961.08 | 2019-2025 | |
| Galderma Laboratories, L.P. | $949.10 | 2019-2025 | Aklief, Nemluvio, Epsolay |
| Sun Pharmaceutical Industries INC. | $771.99 | 2019-2025 | Winlevi, Absorica Ld |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $727.00 | 2019-2025 | Duobrii, Siliq, Cabtreo |
| Leo Pharma INC. | $719.69 | 2019-2025 | Adbry, Anzupgo |
| Almirall LLC | $561.91 | 2019-2025 | Klisyri |
| Ucb, INC. | $517.00 | 2020-2025 | Bimzelx |
| Merz North America, INC. | $505.62 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $489.97 | 2019-2025 | |
| Amgen INC. | $436.90 | 2019-2025 | Otezla, Otezla |
| Vyne Pharmaceuticals INC. | $341.55 | 2020-2021 | |
| Lilly USA, LLC | $324.13 | 2019-2025 | Taltz, Ebglyss, Olumiant |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charisse Mccall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.